JPMorgan's 'Analyst Focus List' – Growth, Income, Value, Short Ideas

Seeking AlphaNov 20 00:06

Xenon to Present at Upcoming Investor Conferences

GlobeNewswireNov 14 05:01

Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus

Zacks Nov 13 23:00

RBC Capital Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Raises Target Price to $56

Futu NewsNov 13 21:31 · Ratings

TD Cowen Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating

Futu NewsNov 13 21:31 · Ratings

A Quick Look at Today's Ratings for Xenon Pharmaceuticals(XENE.US), With a Forecast Between $53 to $60

Futu NewsNov 13 21:00 · Ratings